Skip to content
10-Q

Quarterly Report

APTEVO THERAPEUTICS INC. APVO

0000950170-25-106247

← back to feed
Filed
Aug 11, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 11, 2025 3.29M sh
Shares Diluted Q2 2025 · Jun 30, 2025 738.15K sh
Shares Diluted Q2 2025 · Jun 30, 2025 408.99K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 4.76K sh
Shares Diluted restated Q2 2025 · Jun 30, 2024 2.85K sh
Operating Cash Flow Q2 2025 · Jun 30, 2025 −$13.67M
Operating Cash Flow Q2 2025 · Jun 30, 2024 −$12.8M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $9.41M
Cash And Equivalents Q2 2025 · Dec 31, 2024 $8.71M
Cash And Equivalents Q2 2025 · Jun 30, 2024 $8.07M
Stockholders Equity Q2 2025 · Jun 30, 2025 $6.52M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$1.47M
Stockholders Equity Q2 2025 · Dec 31, 2024 $4.76M
Stockholders Equity Q2 2025 · Jun 30, 2024 $4.46M
Stockholders Equity Q2 2025 · Mar 31, 2024 $6.1M
Stockholders Equity Q2 2025 · Dec 31, 2023 $12.22M
Current Liabilities Q2 2025 · Jun 30, 2025 $4.89M
Current Liabilities Q2 2025 · Dec 31, 2024 $6.21M
Total Liabilities Q2 2025 · Jun 30, 2025 $9.1M
Total Liabilities Q2 2025 · Dec 31, 2024 $10.84M
Current Assets Q2 2025 · Jun 30, 2025 $11.08M
Current Assets Q2 2025 · Dec 31, 2024 $10.66M
Total Assets Q2 2025 · Jun 30, 2025 $15.62M
Total Assets Q2 2025 · Dec 31, 2024 $15.59M
Eps Diluted Q2 2025 · Jun 30, 2025 −$8.40
Eps Diluted Q2 2025 · Jun 30, 2025 −$30.84
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$1,236.96
Eps Diluted restated Q2 2025 · Jun 30, 2024 −$4,458.98
Eps Basic Q2 2025 · Jun 30, 2025 −$8.40
Eps Basic Q2 2025 · Jun 30, 2025 −$30.84
Eps Basic restated Q2 2025 · Jun 30, 2024 −$1,236.96
Eps Basic restated Q2 2025 · Jun 30, 2024 −$4,458.98
Rd Expense Q2 2025 · Jun 30, 2025 $3.33M
Rd Expense Q2 2025 · Jun 30, 2025 $6.96M
Rd Expense Q2 2025 · Jun 30, 2024 $3.64M
Rd Expense Q2 2025 · Jun 30, 2024 $7.4M
Net Income Q2 2025 · Jun 30, 2025 −$6.2M
Net Income Q2 2025 · Jun 30, 2025 −$12.61M
Net Income Q2 2025 · Mar 31, 2025 −$6.41M
Net Income Q2 2025 · Jun 30, 2024 −$5.88M
Net Income Q2 2025 · Jun 30, 2024 −$12.72M
Net Income Q2 2025 · Mar 31, 2024 −$6.83M
Operating Income Q2 2025 · Jun 30, 2025 −$6.23M
Operating Income Q2 2025 · Jun 30, 2025 −$12.71M
Operating Income Q2 2025 · Jun 30, 2024 −$6.02M
Operating Income Q2 2025 · Jun 30, 2024 −$13.01M